{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:40:31Z","timestamp":1788446431471,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":2730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"The Melville Trust for the Care and Cure of Cancer"},{"name":"the Prostate Research Campaign UK"},{"name":"the Charon Charity Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1093\/annonc\/mdr447","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T00:43:13Z","timestamp":1318898593000},"page":"1542-1549","source":"Crossref","is-referenced-by-count":76,"title":["Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"D.J.","family":"Storey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Frew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr447_bb0010","unstructured":"Cancer Research UKUK Cancer Incidence Statistics for Common Cancers. 2011; http:\/\/info.cancerresearchuk.org\/cancerstats\/incidence\/commoncancers\/ (4 May 2011, date last accessed)"},{"key":"10.1093\/annonc\/mdr447_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1093\/annonc\/mdr447_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00042307-200405000-00007","article-title":"Complications of androgen deprivation therapy for prostate cancer","volume":"14","author":"Holzbeierlein","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1093\/annonc\/mdr447_bb0025","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0959-8049(00)00084-8","article-title":"Fatigue in patients with prostate cancer receiving hormone therapy","volume":"36","author":"Stone","year":"2000","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1093\/annonc\/mdr447_bb0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jnci\/94.6.430","article-title":"Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy","volume":"94","author":"Potosky","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr447_bb0035","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2001.19.17.3750","article-title":"Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study","volume":"19","author":"Potosky","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdr447_bb0040","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0022-5347(05)67533-7","article-title":"Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy","volume":"163","author":"Herr","year":"2000","journal-title":"J Urol"},{"issue":"2","key":"10.1093\/annonc\/mdr447_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0302-2838(03)00208-2","article-title":"The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer","volume":"44","author":"Van Andel","year":"2003","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdr447_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/pon.1206","article-title":"Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy","volume":"17","author":"Pirl","year":"2008","journal-title":"Psychooncology"},{"key":"10.1093\/annonc\/mdr447_bb0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1464-410X.2007.07338.x","article-title":"Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975\u20132004","volume":"101","author":"Hussain","year":"2008","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mdr447_bb0060","unstructured":"SIMD. Scottish Index of Multiple Deprivation 2004; http:\/\/www.scotland.gov.uk\/Publications\/2004\/06\/19421\/38085 and http:\/\/www.scotland.gov.uk\/Topics\/Statistics\/SIMD (22 July 2011, date last accessed)"},{"key":"10.1093\/annonc\/mdr447_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0360-3016(98)00475-1","article-title":"Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy","volume":"43","author":"Lilleby","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdr447_bb0070","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","article-title":"The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory","volume":"85","author":"Mendoza","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr447_bb0075","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.10507","article-title":"Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center","volume":"94","author":"Hwang","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr447_bb0080","first-page":"91","article-title":"Measuring and understanding fatigue","volume":"13","author":"Cleeland","year":"1999","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdr447_bb0085","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/1097-0142(20010915)92:6+<1699::AID-CNCR1500>3.0.CO;2-9","article-title":"Fatigue management: evidence and guidelines for practice","volume":"92","author":"Mock","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr447_bb0090","unstructured":"NCCNClinical Practice Guidelines in Oncology: Cancer-Related Fatigue v. 1. 2009http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/fatigue.pdf. (4 May 2011, date last accessed)"},{"key":"10.1093\/annonc\/mdr447_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpainsymman.2006.09.019","article-title":"Women experience higher levels of fatigue than men at the end of life: a longitudinal home palliative care study","volume":"33","author":"Husain","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdr447_bb0100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/annonc\/mdn068","article-title":"Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment","volume":"19","author":"Dimeo","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr447_bb0105","series-title":"In Chapmanand CR, Loeser JD (Eds) Advances in Pain Research and Therapy, Volume 12: Issues in Pain Measurement","first-page":"391","article-title":"Measurement of pain by subjective report","author":"Cleeland","year":"1989"},{"issue":"6","key":"10.1093\/annonc\/mdr447_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1093\/annonc\/mdr447_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"issue":"suppl","key":"10.1093\/annonc\/mdr447_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000474553","article-title":"Influence of urological morbidity on quality of life in patients with prostate cancer","volume":"31","author":"Fossa","year":"1997","journal-title":"Eur Urol"},{"issue":"5","key":"10.1093\/annonc\/mdr447_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr447_bb0130","series-title":"EORTC QLQ-C30 Scoring Manual","author":"Fayers","year":"2001"},{"issue":"1","key":"10.1093\/annonc\/mdr447_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr447_bb0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/028418600750013384","article-title":"Health-related quality of life measured by the EORTC QLQ-C30\u2014reference values from a large sample of Swedish population","volume":"39","author":"Michelson","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mdr447_bb0145","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0959-8049(00)00447-0","article-title":"Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population","volume":"37","author":"Schwarz","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr447_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0269216310367842","article-title":"Symptom clusters: myth or reality?","volume":"24","author":"Aktas","year":"2010","journal-title":"Palliat Med"},{"issue":"11","key":"10.1093\/annonc\/mdr447_bb0155","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/annonc\/mdm349","article-title":"Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study","volume":"18","author":"Storey","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr447_bb0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/annonc\/mdr034","article-title":"Clinically relevant fatigue in recurrence-free prostate cancer survivors","volume":"23","author":"Storey","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr447_bb0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.61.2.162","article-title":"Increased incidence of diagnosed depressive illness in hypogonadal older men","volume":"61","author":"Shores","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1093\/annonc\/mdr447_bb0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00002820-200405000-00007","article-title":"Micturition problems in relation to quality of life in men with prostate cancer or benign prostatic hyperplasia: comparison with men from the general population","volume":"27","author":"Jakobsson","year":"2004","journal-title":"Cancer Nurs"},{"key":"10.1093\/annonc\/mdr447_bb0175","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1200\/JCO.2010.29.8091","article-title":"Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer","volume":"28","author":"Alibhai","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7549","key":"10.1093\/annonc\/mdr447_bb0180","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1093\/annonc\/mdr447_bb0185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1464-410X.1997.00234.x","article-title":"Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade","volume":"79","author":"Strum","year":"1997","journal-title":"Br J Urol"},{"issue":"1","key":"10.1093\/annonc\/mdr447_bb0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1464-410x.1999.00844.x","article-title":"Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer","volume":"83","author":"Ornstein","year":"1999","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mdr447_bb0195","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.2003.09.534","article-title":"Resistance exercise in men receiving androgen deprivation therapy for prostate cancer","volume":"21","author":"Segal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr447_bb0200","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/cncr.20378","article-title":"A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radial external beam radiotherapy for localized prostate carcinoma","volume":"101","author":"Windsor","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr447_bb0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1503\/cmaj.091278","article-title":"Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study","volume":"182","author":"Ling","year":"2010","journal-title":"CMAJ"},{"key":"10.1093\/annonc\/mdr447_bb0210","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1002\/cncr.25424","article-title":"Methylphenidate for fatigue in ambulatory men with prostate cancer","volume":"116","author":"Roth","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr447_bb0215","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ncponc1180","article-title":"Intermittent androgen blockade should be regarded as standard therapy in prostate cancer","volume":"5","author":"Seruga","year":"2008","journal-title":"Nat Clin Pract Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419386995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419386995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/6\/1542\/400126\/mdr447.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T05:28:01Z","timestamp":1624685281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419386995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0923753419386995"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr447","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}